Influence of Spirituality and Modesty on Acceptance of Self-Sampling for Cervical Cancer Screening.

Autor: Eileen O Dareng, Elima Jedy-Agba, Patience Bamisaye, Fatima Isa Modibbo, Lawal O Oyeneyin, Ayodele S Adewole, Olayinka B Olaniyan, Patrick S Dakum, Paul D Pharoah, Clement A Adebamowo

Publikováno v: PLoS ONE, Vol 10, Iss 11, p e0141679 (2015)

Whereas systematic screening programs have reduced the incidence of cervical cancer in developed countries, the incidence remains high in developing countries. Among several barriers to uptake of cervical cancer screening, the roles of religious and

Externí odkaz: https://doaj.org/article/ba83861de02b419ebace8769660b69fd

Attitude to Human Papillomavirus Deoxyribonucleic Acid-Based Cervical Cancer Screening in Antenatal Care in Nigeria: A Qualitative Study

Autor: Temitope E. Filade, Eileen O. Dareng, Toyosi Olawande, Tolani A. Fagbohun, Amos O. Adebayo, Clement A. Adebamowo

Publikováno v: Frontiers in Public Health
Frontiers in Public Health, Vol 5 (2017)

Objectives: Human papillomavirus (HPV) deoxyribonucleic acid (DNA) based testing is increasingly used for cervical cancer screening in developed countries, but the best approach to utilizing it in low and middle-income countries (LMIC) is unclear. In

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b22b629d4d4ced0bf8e5434f83a250e
http://europepmc.org/articles/PMC5592338

Persistent Low-Risk and High-Risk Human Papillomavirus Infections of the Uterine Cervix in HIV-Negative and HIV-Positive Women

Autor: Sally N. Adebamowo, Oluwatoyosi Olawande, Ayotunde Famooto, Eileen O. Dareng, Richard Offiong, Clement A. Adebamowo, for the H3Africa ACCME Research Group

Publikováno v: Frontiers in Public Health, Vol 5 (2017)
Frontiers in Public Health

Background The prevalence, persistence, and multiplicity of human papillomavirus (HPV) infection appears different comparing HIV-positive to HIV-negative women. In this study, we examined prevalent, persistent, and multiple low- and high-risk cervica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c73385294be87f1f877c0ed3f8a01469
https://doi.org/10.3389/fpubh.2017.00178

Cohort Profile: African Collaborative Center for Microbiome and Genomics Research (ACCME)

Autor: Ayotunde O. Famooto, Sally N. Adebamowo, Eileen O. Dareng, Clement Adebamowo, Rasheed A. Bakare

Publikováno v: Journal of Global Oncology. 2:40s-40s

Abstract 65 Background: Cervical cancer is the second most common cancer in Africa. Much remains unknown about the prevalence and pathogenicity of human papillomavirus (HPV) types and the mechanism of disease, and there is a need for new biomarkers f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::48dd211213c05f5d70ec1722a1f3c623
https://doi.org/10.1200/jgo.2016.003822

Clearance of Type-Specific, Low-Risk, and High-Risk Cervical Human Papillomavirus Infections in HIV-Negative and HIV-Positive Women.

Autor: Adebamowo SN; Sally N. Adebamowo and Clement A. Adebamowo, University of Maryland School of Medicine, Baltimore, MD; Sally N. Adebamowo, Ayotunde Famooto, and Clement A. Adebamowo, Center for Bioethics and Research, Ibadan; Ayotunde Famooto and Oluwatoyosi Olawande, Institute of Human Virology Nigeria; Olayinka Olaniyan, National Hospital Abuja; Richard Offiong, University of Abuja Teaching Hospital, Abuja, Nigeria; Eileen O. Dareng, University of Cambridge, Cambridge, United Kingdom., Famooto A; Sally N. Adebamowo and Clement A. Adebamowo, University of Maryland School of Medicine, Baltimore, MD; Sally N. Adebamowo, Ayotunde Famooto, and Clement A. Adebamowo, Center for Bioethics and Research, Ibadan; Ayotunde Famooto and Oluwatoyosi Olawande, Institute of Human Virology Nigeria; Olayinka Olaniyan, National Hospital Abuja; Richard Offiong, University of Abuja Teaching Hospital, Abuja, Nigeria; Eileen O. Dareng, University of Cambridge, Cambridge, United Kingdom., Dareng EO; Sally N. Adebamowo and Clement A. Adebamowo, University of Maryland School of Medicine, Baltimore, MD; Sally N. Adebamowo, Ayotunde Famooto, and Clement A. Adebamowo, Center for Bioethics and Research, Ibadan; Ayotunde Famooto and Oluwatoyosi Olawande, Institute of Human Virology Nigeria; Olayinka Olaniyan, National Hospital Abuja; Richard Offiong, University of Abuja Teaching Hospital, Abuja, Nigeria; Eileen O. Dareng, University of Cambridge, Cambridge, United Kingdom., Olawande O; Sally N. Adebamowo and Clement A. Adebamowo, University of Maryland School of Medicine, Baltimore, MD; Sally N. Adebamowo, Ayotunde Famooto, and Clement A. Adebamowo, Center for Bioethics and Research, Ibadan; Ayotunde Famooto and Oluwatoyosi Olawande, Institute of Human Virology Nigeria; Olayinka Olaniyan, National Hospital Abuja; Richard Offiong, University of Abuja Teaching Hospital, Abuja, Nigeria; Eileen O. Dareng, University of Cambridge, Cambridge, United Kingdom., Olaniyan O; Sally N. Adebamowo and Clement A. Adebamowo, University of Maryland School of Medicine, Baltimore, MD; Sally N. Adebamowo, Ayotunde Famooto, and Clement A. Adebamowo, Center for Bioethics and Research, Ibadan; Ayotunde Famooto and Oluwatoyosi Olawande, Institute of Human Virology Nigeria; Olayinka Olaniyan, National Hospital Abuja; Richard Offiong, University of Abuja Teaching Hospital, Abuja, Nigeria; Eileen O. Dareng, University of Cambridge, Cambridge, United Kingdom., Offiong R; Sally N. Adebamowo and Clement A. Adebamowo, University of Maryland School of Medicine, Baltimore, MD; Sally N. Adebamowo, Ayotunde Famooto, and Clement A. Adebamowo, Center for Bioethics and Research, Ibadan; Ayotunde Famooto and Oluwatoyosi Olawande, Institute of Human Virology Nigeria; Olayinka Olaniyan, National Hospital Abuja; Richard Offiong, University of Abuja Teaching Hospital, Abuja, Nigeria; Eileen O. Dareng, University of Cambridge, Cambridge, United Kingdom., Adebamowo CA; Sally N. Adebamowo and Clement A. Adebamowo, University of Maryland School of Medicine, Baltimore, MD; Sally N. Adebamowo, Ayotunde Famooto, and Clement A. Adebamowo, Center for Bioethics and Research, Ibadan; Ayotunde Famooto and Oluwatoyosi Olawande, Institute of Human Virology Nigeria; Olayinka Olaniyan, National Hospital Abuja; Richard Offiong, University of Abuja Teaching Hospital, Abuja, Nigeria; Eileen O. Dareng, University of Cambridge, Cambridge, United Kingdom.

Publikováno v: Journal of global oncology [J Glob Oncol] 2018 Jul; Vol. 4, pp. 1-12.